K

Khartis

HealthOral Medications

Khartis is a biopharmaceutical company focused on developing innovative oral therapies. The company aims to provide effective alternatives to existing treatments, specifically targeting conditions treated by Tepezza. This funding round will support their efforts in advancing their oral challenger to Tepezza.

Visit website ↗
Total raised
$95M
tracked to date
Latest round
$95M
Aug 14, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    $95MAug 14, 2026
    Announcement ↗

Khartis in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile